Complex regional pain syndromes: new pathophysiological concepts and therapies

被引:110
作者
Maihoefner, C. [1 ,2 ]
Seifert, F. [1 ]
Markovic, K. [1 ]
机构
[1] Univ Hosp Erlangen, Dept Neurol, Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Physiol & Expt Pathophysiol, D-91054 Erlangen, Germany
关键词
causalgia; complex regional pain syndrome; neuropathic pain; reflex sympathetic dystrophy; Sudeck's dystrophy; sympathetically maintained pain; therapy; REFLEX SYMPATHETIC DYSTROPHY; SYNDROME TYPE-I; RANDOMIZED CONTROLLED-TRIAL; SPINAL-CORD STIMULATION; GENE-RELATED PEPTIDE; FACILITATED NEUROGENIC INFLAMMATION; NECROSIS-FACTOR-ALPHA; GRADED MOTOR IMAGERY; GLUCOCORTICOID INHIBITION; NEUROPATHIC PAIN;
D O I
10.1111/j.1468-1331.2010.02947.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Complex regional pain syndrome (CRPS), formerly known as Sudeck's dystrophy and causalgia, is a disabling and distressing pain syndrome. We here provide a review based on the current literature concerning the epidemiology, etiology, pathophysiology, diagnosis, and therapy of CRPS. CRPS may develop following fractures, limb trauma or lesions of the peripheral or CNS. The clinical picture comprises a characteristic clinical triad of symptoms including autonomic (disturbances of skin temperature, color, presence of sweating abnormalities), sensory (pain and hyperalgesia), and motor (paresis, tremor, dystonia) disturbances. Diagnosis is mainly based on clinical signs. Several pathophysiological concepts have been proposed to explain the complex symptoms of CRPS: (i) facilitated neurogenic inflammation; (ii) pathological sympatho-afferent coupling; and (iii) neuroplastic changes within the CNS. Furthermore, there is accumulating evidence that genetic factors may predispose for CRPS. Therapy is based on a multidisciplinary approach. Non-pharmacological approaches include physiotherapy and occupational therapy. Pharmacotherapy is based on individual symptoms and includes steroids, free radical scavengers, treatment of neuropathic pain, and finally agents interfering with bone metabolism (calcitonin, biphosphonates). Invasive therapeutic concepts include implantation of spinal cord stimulators. This review covers new aspects of pathophysiology and therapy of CRPS.
引用
收藏
页码:649 / 660
页数:12
相关论文
共 129 条
[1]  
AbuRahma A F, 1994, Ann Vasc Surg, V8, P372, DOI 10.1007/BF02133000
[2]   Bisphosphonate therapy of reflex sympathetic dystrophy syndrome [J].
Adami, S ;
Fossaluzza, V ;
Gatti, D ;
Fracassi, E ;
Braga, V .
ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (03) :201-204
[3]   Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients [J].
Allen, G ;
Galer, BS ;
Schwartz, L .
PAIN, 1999, 80 (03) :539-544
[4]   FEATURES OF ALGODYSTROPHY AFTER COLLES FRACTURE [J].
ATKINS, RM ;
DUCKWORTH, T ;
KANIS, JA .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1990, 72 (01) :105-110
[5]   ALGODYSTROPHY FOLLOWING COLLES FRACTURE [J].
ATKINS, RM ;
DUCKWORTH, T ;
KANIS, JA .
JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME, 1989, 14B (02) :161-164
[6]   Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study [J].
Baron, R ;
Schattschneider, J ;
Binder, A ;
Siebrecht, D ;
Wasner, G .
LANCET, 2002, 359 (9318) :1655-1660
[7]   Successful intravenous regional block with low-dose tumor necrosis factor-α antibody infliximab for treatment of complex regional pain syndrome 1 [J].
Bernateck, Michael ;
Rolke, Roman ;
Birklein, Frank ;
Treede, Rolf-Detlef ;
Fink, Matthias ;
Karst, Matthias .
ANESTHESIA AND ANALGESIA, 2007, 105 (04) :1148-1151
[8]  
BICKERSTAFF DR, 1994, BRIT J RHEUMATOL, V33, P240
[9]  
BICKERSTAFF DR, 1991, BRIT J RHEUMATOL, V30, P291
[10]   Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS) [J].
Birklein, F ;
Weber, M ;
Ernst, M ;
Riedl, B ;
Neundörfer, B ;
Handwerker, HO .
PAIN, 2000, 87 (02) :227-234